BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17228008)

  • 1. Letter by Ben-Dov and Bursztyn regarding article, "Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial".
    Ben-Dov IZ; Bursztyn M
    Circulation; 2007 Jan; 115(2):e18; author reply e19. PubMed ID: 17228008
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by barrios et Al regarding article, "heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial".
    Barrios V; Escobar C; Echarri R
    Circulation; 2009 Aug; 120(5):e31; author reply e32. PubMed ID: 19652116
    [No Abstract]   [Full Text] [Related]  

  • 3. A family physician questions the conclusions from ALLHAT.
    Standridge JB
    Am J Hypertens; 2004 Apr; 17(4):361-5. PubMed ID: 15062891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Trial: focus on the diabetic patient.
    Berecek KH; Farag A; Bahtiyar G; Rothman J; McFarlane SI
    Curr Hypertens Rep; 2004 Jun; 6(3):212-4. PubMed ID: 15128474
    [No Abstract]   [Full Text] [Related]  

  • 5. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
    Beevers DG; Lee KW; Lip GY
    J Hum Hypertens; 2003 Jun; 17(6):367-72. PubMed ID: 12764397
    [No Abstract]   [Full Text] [Related]  

  • 6. The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohort.
    Hebert LA; Rovin BH; Hebert CJ
    Nat Clin Pract Nephrol; 2007 Feb; 3(2):60-1. PubMed ID: 17251990
    [No Abstract]   [Full Text] [Related]  

  • 7. ALLHAT: the largest and most important clinical trial in hypertension ever done in the USA. Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial.
    Elliott WJ
    Am J Hypertens; 1996 Apr; 9(4 Pt 1):409-11. PubMed ID: 8722446
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U;
    Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amlodipine or lisinopril was not better than chlorthalidone in lowering CHD risk in hypertension.
    Heckman GA; Psaty BM
    ACP J Club; 2003; 139(3):A15; author reply A15. PubMed ID: 14594435
    [No Abstract]   [Full Text] [Related]  

  • 10. [ALLHAT's clamour, referee's and editor's compassion, and Hasan Pulur].
    Timuralp B
    Anadolu Kardiyol Derg; 2003 Sep; 3(3):197-8. PubMed ID: 12967882
    [No Abstract]   [Full Text] [Related]  

  • 11. [Uneven sex distribution in the cardiovascular trials--an exaggerated problem].
    Melander H; Rastad JA
    Lakartidningen; 2006 Jun 8-13; 103(23):1856-9. PubMed ID: 16838599
    [No Abstract]   [Full Text] [Related]  

  • 12. [Life style, surveillance and treatment of the recovered infarct patient].
    Guize L
    Rev Prat; 1974 Dec 7-11; 24(55):5131-6. PubMed ID: 4445782
    [No Abstract]   [Full Text] [Related]  

  • 13. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
    Haywood LJ; Ford CE; Crow RS; Davis BR; Massie BM; Einhorn PT; Williard A;
    J Am Coll Cardiol; 2009 Nov; 54(22):2023-31. PubMed ID: 19926008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [After the ALLHAT trial, what do we know about treatment for hypertension that we did not know before?].
    González-Juanatey JR
    Rev Esp Cardiol; 2003 Jul; 56(7):642-8. PubMed ID: 12855144
    [No Abstract]   [Full Text] [Related]  

  • 15. Network meta-analysis of heart failure prevention by antihypertensive drugs.
    Elliott WJ; Basu S; Meyer PM
    Arch Intern Med; 2011 Mar; 171(5):472; author reply 472-3. PubMed ID: 21403048
    [No Abstract]   [Full Text] [Related]  

  • 16. Trials and tribulations.
    Packard CJ
    Int J Clin Pract Suppl; 2002 Oct; (132):3-10. PubMed ID: 12425357
    [No Abstract]   [Full Text] [Related]  

  • 17. Reappraisal of the role of diuretics in heart failure.
    Guglin M
    Cardiol Rev; 2009; 17(2):56-9. PubMed ID: 19367146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart lines. Cardura update.
    Harv Heart Lett; 2001 Sep; 12(1):5-6. PubMed ID: 11572810
    [No Abstract]   [Full Text] [Related]  

  • 19. A diuretic for initial treatment of hypertension.
    Med Lett Drugs Ther; 2009 Feb; 51(1305):9-10. PubMed ID: 19197232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis.
    Bangalore S; Wild D; Parkar S; Kukin M; Messerli FH
    J Am Coll Cardiol; 2008 Sep; 52(13):1062-72. PubMed ID: 18848139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.